| 1 |
30121250 | JNK-AKT-NF-κB controls P-glycoprotein expression to attenuate the cytotoxicity of deoxynivalenol in mammalian cells. | 2018 Oct |
1 |
| 2 |
22249269 | c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. | 2012 Nov 1 |
1 |
| 3 |
22615609 | Primary WWOX phosphorylation and JNK activation during etoposide induces cytotoxicity in HEK293 cells. | 2010 |
5 |
| 4 |
19424800 | c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells. | 2009 Jun |
3 |
| 5 |
19492242 | JWA sensitizes P-glycoprotein-mediated drug-resistant choriocarcinoma cells to etoposide via JNK and mitochondrial-associated signal pathway. | 2009 |
1 |
| 6 |
20552320 | Distinct roles for JNK1 and JNK3 during TNF-alpha- or etoposide-induced apoptosis in HeLa cells. | 2009 Dec 31 |
2 |
| 7 |
18164262 | Phosphorylation of eIF-4E positively regulates formation of the eIF-4F translation initiation complex following DNA damage. | 2008 Feb 29 |
1 |
| 8 |
18174237 | Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. | 2008 Mar |
1 |
| 9 |
18270325 | Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. | 2008 Apr 15 |
1 |
| 10 |
16709574 | JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. | 2006 Jul 28 |
1 |
| 11 |
15788689 | Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. | 2005 Mar 15 |
2 |
| 12 |
15832344 | JNK/p53 mediated cell death response in K562 exposed to etoposide-ionizing radiation combined treatment. | 2005 Jun 1 |
5 |
| 13 |
15001534 | Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. | 2004 Jul |
1 |
| 14 |
12663670 | The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. | 2003 Jun 6 |
1 |
| 15 |
12707267 | c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. | 2003 Jul 11 |
2 |
| 16 |
12712406 | c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. | 2003 Jun 1 |
2 |
| 17 |
12815281 | cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide. | 2003 Aug |
1 |
| 18 |
12907245 | The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. | 2003 Aug 1 |
1 |
| 19 |
12417047 | Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells. | 2002 Oct |
4 |
| 20 |
10454518 | Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation. | 1999 Sep |
2 |
| 21 |
9533766 | 2-Deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activation. | 1998 Mar 30 |
3 |
| 22 |
9020192 | c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. | 1997 Feb 14 |
1 |
| 23 |
14646555 | Serum withdrawal and etoposide induce apoptosis in human lung carcinoma cell line A549 via distinct pathways. | 1997 |
1 |
| 24 |
8940082 | Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. | 1996 Nov 29 |
1 |